CBI’s Fifth Annual Pharmaceutical/​Biotech Tax and Transfer Pricing Congress

Addresses the tax and transfer pricing issues distinctive to the life sciences industry, including latest tax rulings, available tax credits for R&D companies and legislative developments impacting state, federal and global taxation.

Sanford Stark presents Codification of Economic Substance — Does It Really Change Anything on November 4, 2010.